An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy

C. L. Meinert

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)273-284
Number of pages12
JournalControlled clinical trials
Issue number4
StatePublished - 1996

ASJC Scopus subject areas

  • Pharmacology

Cite this